US equities |
SPCX $171.09 ▲+0.00% NVDA $238.90 ▲+0.00% MU $1,063.96 ▲+0.00% AMD $631.75 ▲+0.00% SNDK $1,704.16 ▲+0.00% TSLA $378.73 ▲+0.00% SKHY $195.02 ▲+0.00% INTC $116.19 ▲+0.00%
FinancialContent

Latest News about Genprex

Recent news which mentions Genprex

Genprex – FDA Grants Fast Track Approval For Promising New Cancer Gene Therapy
Tickers GNPX
Tags Genprex Market News GNPX
From Benzinga
Genprex (NASDAQ: GNPX) Releases New Patient Video Interview Describing Positive Experience in Clinical Trial
Tickers BLUE EDIT GNPX
Tags Small Cap GNPX Genprex
From Benzinga
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
Tickers AMGN AZN BIIB BLUE
Tags Genprex Market News BIIB
From Benzinga